Last week, 26 members of the U.S. House of Representatives wrote acting FDA Commissioner Ned Sharpless, urging the agency to quickly adopt a policy and consider issuing an interim final rule to regulate CBD as a food additive and dietary supplement. They also asked the FDA to move forward with a “robust framework” to assess safety and accurate labeling of CBD products.
A Republican congressman brought two CBD products he personally uses to a hearing last Tuesday to demonstrate the differences between hemp and marijuana.
During a House Oversight Committee meeting on the recent spike in vaping-related injuries, Rep. James Comer (R-KY) said he wanted to spend his time “talking about CBD because I believe there’s a lot of misinformation and confusion about exactly what CBD is and what THC is.”
That’s because of all the studies proving CBD has major health benefits. In fact, CBD oil has been proven to alleviate stress, anxiety, pain, and inflammation by impacting our bodies’ pain receptors.
New York Gov. Andrew Cuomo announced on Tuesday that he plans to meet with the governors of Connecticut and New Jersey to discuss ways to create consistency within each state’s respective marijuana programs as they move forward with plans to legalize.
Late last week, Ludlow Research made note that CBD stocks were down nearly 50-70% from their recent highs, and proposed bullish changes to regulations in the US Senate could trigger short covering within the sector as a whole.
American Premium Water Corp. (OTC: HIPH) is particularly well-positioned to profit from the cannabis boom and investors should be well rewarded and can expect the companys revenue and profits to head even higher in the year ahead.
The company has set its sights on international expansión and recently announced that it has engaged in discussions with distributors in Australia, Mexico, and Colombia to sell the Company’s products. Both CBD and non-CBD products will be sold to these distributors. Exploratory discussions are also underway with distributors in the Pacific Rim region. The Company expects sales to begin in these regions in the 3rd and 4th quarter of 2019.
In a recent press release, the company announced that it has secured a contract through its UK subsidiary, which will generate over $833,000 of topline revenue. This is the largest contract for the Company to date, and puts the Company on a firm track to exceed its previously issued 2019 revenue guidance of $1 million.
The company have also setup a relationship with Hanlons Brewery to manufacture CBD infused beer. In addition the team established a partnership with Lynne Franks to produce CBD infused women’s wellness products.
American Premium Water (OTC: HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of hydrogen and Nano technologies paired with cannabidiol (CBD) to treat health disorders and enhance quality of life. This business model aims to market emerging fashion brands by leveraging classic retail partners and incorporating disruptive blockchain technologies to expand the retail footprint. The company’s portfolio includes the LALPINA Hydro and LALPINA Hydro CBD brands (www.LalpinaInc.com), LALPINA Productions, LALPINA Records, Canyon Create (www.canyoncreate.com), Vanexxe (www.vanexxe.com) Gents (www.gentsco.com).
We believe the market is undervaluing HIPH’s strong long-term top-line growth potential. The Company was recently given a short-term price target of $0.05-$0.06 by Ludlow Research.